Report: Emerging pharma markets to see USD 96 drug spending per capita by 2016, includes Romania
Emerging markets, including Romania, will cover around a third of worldwide drug sales by 2016, up from 20 percent in 2011, according to a report from the IMS Institute for Healthcare Informatics.
Romania is part of a group of pharmerging markets, which also includes China, Brazil, India, Russia, Mexico, Turkey, Poland, Venezuela, Argentina, Indonesia, South Africa, Thailand, Egypt, Ukraine, Pakistan and Vietnam. Pharmerging tier 3, which includes Romania but excludes China, India, Russia and Brazil, has a population of around 1 billion people. They are likely to spend some USD 96 per capita in 2016, below the USD 121 for China but above USD 33 for India. Pharmaceutical spending per capita in 2016 is estimated to vary between USD 892 in the US, which is the highest, at a population of 326 million, to USD 33 in India, with a population of 1.2 billion.
In pharmerging countries, 40 percent of the population will have yearly household incomes over USD 5,000 by 2016, an increase of 494 million people compared to 2011, according to the report.
Pharmerging countries are defined as those with greater than USD 1 billion absolute spending growth over 2012-16 and which have GDP per capita of less than USD 25,000 at purchasing power parity.
editor@romania-insider.com
(photo source: sxc.hu)
